RxDoctor Payments Data

Albert Mims, MD

Family Medicine · Lake City, SCNPI 1609972314

Payments from drug & device makers

$450in general payments, 2019–2025

Across 32 payments — averaging $14.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$63
  • Johnson & Johnson$46
  • Astellas Pharma US Inc$37
  • Hikma Pharmaceuticals USA$36
  • Kowa Pharmaceuticals America, Inc.$32
  • Amarin Pharma, Inc.$28
  • plus $208 from 13 others

What the payments were for

  • Food & beverage$450100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$450 in reported general payments places this provider in the 45th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$49,513
Medicare patients
120
Services billed
1,144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide206$225,434
EliquisApixaban193$170,291
JanuviaSitagliptin Phosphate109$92,840
OzempicSemaglutide87$88,600
JardianceEmpagliflozin86$86,829
LinzessLinaclotide139$84,964
FarxigaDapagliflozin Propanediol87$62,475
Invega SustennaPaliperidone Palmitate12$48,266
Trelegy ElliptaFluticasone/Umeclidin/Vilanter62$45,491
XareltoRivaroxaban58$39,661
VraylarCariprazine Hcl20$31,284
TradjentaLinagliptin29$31,217
EntrestoSacubitril/Valsartan30$30,662
MyrbetriqMirabegron25$18,937
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$13,573

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$12$225,434206 claims
PfizerEliquis$12$170,291193 claims
AbbVieLinzess, Vraylar$15$116,249159 claims
MerckJanuvia, Janumet Xr$11$103,306128 claims
Johnson & JohnsonInvega Sustenna, Xarelto$46$87,92670 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$14$82,033128 claims
NovartisEntresto$12$30,66230 claims
Astellas Pharma US IncMyrbetriq$37$18,93725 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Lake City

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →